Synergetic Effects of PARP Inhibitor AZD2281 and Cisplatin in Oral Squamous Cell Carcinoma in Vitro and in Vivo

Cisplatin is a commonly used chemotherapeutic drug for treatment of oral carcinoma, and combinatorial effects are expected to exert greater therapeutic efficacy compared with monotherapy. Poly(ADP-ribosyl)ation is reported to be involved in a variety of cellular processes, such as DNA repair, cell d...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Mol Sci
Main Authors: Yasukawa, Masaaki, Fujihara, Hisako, Fujimori, Hiroaki, Kawaguchi, Koji, Yamada, Hiroyuki, Nakayama, Ryoko, Yamamoto, Nanami, Kishi, Yuta, Hamada, Yoshiki, Masutani, Mitsuko
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4813136/
https://ncbi.nlm.nih.gov/pubmed/26927065
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms17030272
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados